or
forgot password
  • cancer clinical trials in lubbock, TX

  • A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
    Lubbock Dermatology and Skin Cancer Center
    Lubbock, Texas 79410
    Atopic Dermatitis
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Covenant Medical Center-Lakeside
    Lubbock, Texas 79410
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Patients With Advanced Non-Small Cell Lung Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Non-Small Cell Lung Carcinoma
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Texas Tech University Health Sciences Center
    Lubbock, Texas 79430
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Covenant Health System dba Joe Arrington Cancer Research & Treatment Center
    Lubbock, Texas 79410
    Breast Cancer
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Esophageal Cancer
    Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    Texas Tech University Health Sciences Center
    Lubbock, Texas 79430
    Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Texas Tech University Health Sciences Center
    Lubbock, Texas 79430
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma
    Covenant Health System DBA Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410
    Malignant Melanoma
    Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
    Covenant Medical Center-Lakeside
    Lubbock, Texas 79410
    Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma
    Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Leukemia, Neoplasm of Uncertain Malignant Potential, Unspecified Childhood Solid Tumor, Protocol Specific
    Study of Kidney Tumors in Young Patients
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Kidney Cancer, Nonneoplastic Condition
    Collecting and Storing Tissue From Young Patients With Cancer
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Cancer
    Collecting and Storing Biological Samples From Young Patients With Hodgkin's Lymphoma
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Lymphoma
    Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Adult Rhabdomyosarcoma, Childhood Desmoplastic Small Round Cell Tumor, Chordoma, Desmoid Tumor, Metastatic Childhood Soft Tissue Sarcoma, Nonmetastatic Childhood Soft Tissue Sarcoma, Previously Treated Childhood Rhabdomyosarcoma, Previously Untreated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma, Recurrent Childhood Soft Tissue Sarcoma, Stage I Adult Soft Tissue Sarcoma, Stage II Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Brain and Central Nervous System Tumors
    S9925: Collecting and Storing Samples From Patients With Lung Cancer
    UMC Southwest Cancer and Research Center
    Lubbock, Texas 79415-3364
    Lung Cancer
    Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Diffuse Hyperplastic Perilobar Nephroblastomatosis, Rhabdoid Tumor of the Kidney, Stage I Wilms Tumor, Stage II Wilms Tumor, Stage III Wilms Tumor, Stage IV Wilms Tumor, Stage V Wilms Tumor
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Colorectal Cancer, Precancerous Condition
    Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage IV Childhood Hodgkin Lymphoma
    BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Renal Cell Carcinoma
    Conservative Surgery for Women With Cervical Cancer
    Texas Tech University HSC
    Lubbock, Texas 79430
    Cervical Cancer
    Immunotherapy Study for Surgically Resected Pancreatic Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Pancreatic Cancer
    Connectâ„¢ CLL: The Chronic Lymphocytic Leukemia Disease Registry
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Chronic Lymphocytic Leukemia
    Connect® MM- The Multiple Myeloma Disease Registry
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Multiple Myeloma
    LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
    1200.75.10014 Boehringer Ingelheim Investigational Site
    Lubbock, Texas
    Breast Neoplasms
    Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia
    Covenant Children's Hospital
    Lubbock, Texas 79410
    B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    BRCA Mutations in Latinas
    Southwest Cancer Treatment and Research Center, Lubbock; Texas Tech University
    Lubbock, Texas 79415
    Breast Neoplasms
    A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Acute Myeloid Leukemia
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    UMC Southwest Cancer and Research Center
    Lubbock, Texas 79415-3364
    Prostate Cancer
    Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma, Follicular Grade 3 Lymphoma
    A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
    Southwest Cancer Treatment & Research Center
    Lubbock, Texas 79415
    Hematological Malignancies, Certain Lysosomal Storage and Peroxisomal Enzyme Deficiency Disorders, Hurler Syndrome (MPS I), Krabbe Disease (Globoid Leukodystrophy), X-linked Adrenoleukodystrophy, Primary Immunodeficiency Diseases, Bone Marrow Failure, Beta-thalassemia
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    Covenant Children's Hospital
    Lubbock, Texas 79410
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Efficacy and Safety of BC-819 and Gemcitabine in Patients With Locally Advanced Pancreatic Adenocarcinoma
    Joe Arrington Cancer Research & Treatment Center
    Lubbock, Texas 79410
    Pancreas, Adenocarcinoma
    A Study to Evaluate the Efficacy and Safety of GS-6624 Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Pancreatic Cancer
    Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Follicular Lymphoma
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Colorectal Cancer
    Fenretinide/LXS Oral Powder Plus Ketoconazole in Recurrent Ovarian Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Ovarian Cancer, Cancer of Ovary, Cancer of the Ovary, Ovary Neoplasms, Primary Peritoneal Carcinoma
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Texas Tech University Health Sciences Center

    Trial Locations
    Texas Tech University Health Sciences Center
    Covenant Medical Center-Lakeside
    Breast Cancer
    Comparison of Neoadjuvant Chemotherapy With Weekly Paclitaxel or Eribulin Followed by A/C in Women With Locally Advanced HER2-Negative Breast Cancer
    Joe Arrington Cancer Research & Treatment Center
    Lubbock, Texas 79410
    Breast Cancer, HER2-negative Breast Cancer
    The Change Cycle Intervention for Improving Quality of Life in Breast Cancer Survivors
    Texas Tech University Health Sciences Center
    Lubbock, Texas 79430
    Breast Cancer
    Radiation Therapy Plus Chemotherapy in Treating Patients With Supratentorial Glioblastoma Multiforme
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Brain and Central Nervous System Tumors
    Radiation Therapy With or Without Chemotherapy in Treating Patients With Anaplastic Oligodendroglioma
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Brain and Central Nervous System Tumors
    Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Lung Cancer
    Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor, Testicular Germ Cell Tumor
    Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Prostate Cancer
    Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
    Covenant Children's Hospital
    Lubbock, Texas 79410
    Kidney Cancer
    Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Breast Cancer
    SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previously Untreated Acute Lymphocytic Leukemia
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Leukemia, Neutropenia, Thrombocytopenia
    Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Breast Cancer
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Metastatic Cancer
    Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
    Texas Tech University Health Science Center
    Lubbock, Texas 79415
    Head and Neck Cancer
    Marimastat in Treating Patients With Stage III Non-Small Cell Lung Cancer
    Joe Arrington Cancer Research and Treatment Center
    Lubbock, Texas 79410-1894
    Lung Cancer